Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
British Journal of Clinical Pharmacology|October 18, 2022
General clinical and methodological considerations on the extrapolation of pharmacokinetics and optimization of study protocols for small molecules and monoclonal antibodies in childrenNaïm Bouazza, Aristides Dokoumetzidis, Catherijne A J Knibbe, et al.
BMJ Open|June 23, 2017
The CLOSED trial; CLOnidine compared with midazolam for SEDation of paediatric patients in the intensive care unit: study protocol for a multicentre randomised controlled trialAntje Neubert, Manuel Alberto Baarslag, Monique van Dijk, et al.
The Journal of Investigative Dermatology|February 21, 2025
Personalizing Biologic Therapy in Psoriasis: Development, Validation, and User Testing of a Precision-Dosing DashboardCharlotte M Thomas, David Baudry, Zehra Arkir, et al.
Plos Medicine|October 19, 2022
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19David M Lowe, Li-An K Brown, Kashfia Chowdhury, et al.
British Journal of Clinical Pharmacology|February 15, 2026
Pharmacokinetic-pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real-world dataCharlotte M Thomas, Jessica Ruoheng Wei, David Baudry, et al.
The Lancet. Microbe|April 26, 2026
Nirmatrelvir-ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022-23: virological and immunological results of an open-label randomised trial (PANORAMIC)David M Lowe, Shengyuan Zhang, Samuel Ellis, et al.
Advanced Functional Materials|June 17, 2022
Integrin-Targeted, Short Interfering RNA Nanocomplexes for Neuroblastoma Tumor-Specific Delivery Achieve <i>MYCN</i> Silencing with Improved SurvivalAristides D Tagalakis, Vignesh Jayarajan, Ruhina Maeshima, et al.
BMJ Supportive & Palliative Care|February 20, 2022
Diamorphine pharmacokinetics and conversion factor estimates for intranasal diamorphine in paediatric breakthrough pain:systematic reviewSilke Gastine, James D Morse, Miriam Ty Leung, et al.
Npj Antimicrobials and Resistance|May 29, 2026
Polymerase-inhibitor drug synergy and mutational signatures in different epithelial cell models of RSVA and hPIV3 infectionSamuel Ellis, Amy I Jacobs, Shengyuan Zhang, et al.
The Journal of Antimicrobial Chemotherapy|June 28, 2021
Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reportingZahra Sadouki, Timothy D McHugh, Rob Aarnoutse, et al.
Pageof 14